-
The Applications of (17a,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3
Time of Update: 2023-04-27
In this article, we will explore the various applications of (17a,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3- in the chemical industry, ranging from its use as a building block for the synthesis of complex molecules to its application as a catalyst in chemical reactions.
-
The Zambia Chamber of Miners sought government relief measures in response to the crisis
Time of Update: 2023-01-02
In a statement, the chamber said it had submitted an extensive phased economic plan to the government to urgently address the economic impact caused by the coronavirus pandemic.
-
Apple's Samsung sales tactics are diametrically opposite, and many mobile phone manufacturers cut their product lines
Time of Update: 2022-11-24
apple Mobile World Congress (MWC) 2018 will kick off next Monday in Barcelona, where many of the world's largest smartphone brands will take advantage of the event to showcase their latest products on the world stage.
-
Nature: 386 experts in 112 countries around the world propose the most effective measures to end the coronavirus public health threat
Time of Update: 2022-11-15
41 consensus statements and 57 recommendations communicate health systemsVaccination prevention and treatment to help outbreaks inequality vaccine+Top 10 recommendationsTop 10 recommendations Links to papers: Paper LinkEssay Link: Jeffrey Lazarus of the University of Barcelona in Spain and others have analysed lessons learned over the past three years to propose the most effective measures to end the coronavirus public health threat through a rigorous consensus-building approach.
-
【2022 ESMO】Breaking the cocoon into a butterfly, born to the new Professor Wang Zhijie: EGFR ex20ins non-small cell lung cancer treatment field adds a new evidence
Time of Update: 2022-10-03
Among them, the data received by Amivantamab (AMI group) were from the CHRYSALIS study; Data for the RW treatment regimen (external control group) are from the Japanese cohort of EGFR ex20ins mutations in advanced NSCLC who received docetaxel (DOC)/tyrosine kinase inhibitor (TKI)/immunotherapy (IO) for the first time after platinum chemotherapy failure screened by the Asian Lung Cancer Genome Monitoring Platform (LC-SCRUM-Asia).
-
Recently, many multinational pharmaceutical companies have made frequent moves
Time of Update: 2022-05-23
Recently, many multinational pharmaceutical companies, including Takeda Pharmaceuticals, Johnson & Johnson, and Fuji Irvine Biotechnology, have made frequent moves, mainly including merging product lines, building new business experience centers, and innovation cooperation centers .
-
CStone Announces Acceptance of New Drug Application for Pralsetinib for the Treatment of RET Fusion Non-Small Cell Lung Cancer in Hong Kong, China
Time of Update: 2022-04-25
33em } SUZHOU, March 18, 2022 /PRNewswire/ -- CStone Pharmaceuticals (SEHK: 2616), a leading biopharmaceutical company focusing on the research, development and commercialization of innovative immuno-oncology and precision medicines, today Announced that the New Drug Application of the selective RET inhibitor pralsetinib for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with positive transfection rearrangement (RET) gene fusion has been accepted in Hong Kong, China .
-
Ascent Pharma’s Bcl-2 selective inhibitor APG-2575 for the treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma for the key registration phase II clinical study
Time of Update: 2022-01-11
HK) announced today that the company is developing an original class 1 new drug Bcl-2 selective inhibitor lisaftoclax (APG-2575) for the treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (R/R CLL) /SLL)’s key registration phase II clinical study (APG2575CC201) was approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration .
-
Ningbo project fully launched Shanghai Petrochemical Inspection and Modification
Time of Update: 2021-10-07
Sinopec News Network News On the afternoon of March 23, Ningbo Engineering Shanghai Jinshan Branch held a Shanghai Petrochemical 2021 inspection and modification mobilization meeting to clarify the inspection, modification, construction safety and technical quality, "six to six creation" labor competition mobilization, and subcontractors Statements, the flag-giving ceremony of the party member vanguard and the youth commando team, etc.
-
The new mutant strain "MU" has lost 40 countries, and Israel wants to start the fourth "strengthening shot
Time of Update: 2021-09-18
It is understood that considering that the new variant will weaken the efficacy of the vaccine, Israel will receive the fourth dose on the 7th day after the completion of the third dose of the new crown vaccine, in order to effectively improve humoral and cellular immunity .
-
Tan Desai calls for a two-month suspension of immunization of the new crown vaccine
Time of Update: 2021-09-03
. Tan Desai called on countries preparing for the booster shot to share the vaccine with other countries to increase the coverage of their first and second doses of vaccine .
-
15 new African swine fever outbreaks in Bhutan, Germany and Latvia on June 7, 2021
Time of Update: 2021-06-16
Data source: World Organization for Animal Health On June 7, 2021, Bhutan has a new outbreak of swine African swine fever ; Germany has a new outbreak of wild boar African swine fever; and Latvia has a new outbreak of wild boar African swine fever .
-
Industry | Anand Srinivasan will serve as Covestro India's new managing director
Time of Update: 2021-03-28
Korth Chong India has announced the appointment of the current polycarbonate polycarbonate department heads Sriniv Anand ASA the n-as the new managing director.
This position was originally held by Ajay Durrani, who served as the managing director of Covestro India for six years.
-
Zhuobao Technology: You dare not check out for no reason I dare to leak double the compensation
Time of Update: 2021-02-15
Zhuobao Technology: You dare not check out I dare to double the amount of water leakage Zhuobao Technology: You dare not have a reason to check out I dare to double the amount of water In China's waterproof industry, there is a waterproof enterprise to do the first crab eater, bold commitment "once leakage, double compensation", for the building waterproof quality endorsement, for the people to live in peace to provide protection.
-
Beijing issues a list of building materials that are restricted and prohibited from use
Time of Update: 2021-02-11
On April 28th, the relevant person in charge of the Beijing Municipal Housing and Construction Commission introduced that the Beijing Municipal Housing and Construction Commission, the Municipal Planning Commission and the Municipal Municipal Commission jointly released the "Beijing Promotion, Limitation and Prohibition of the Use of Building Materials Directory", the new version of the directory expanded the scope of restricted and banned building materials, in order to reduce the energy consumption of building operation.
